News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management
Sumanta K. Pal/X
Jan 26, 2025, 08:41

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Sumanta K. Pal, Medical Oncologist at City of Hope, posted the following on X:

“Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management (local v systemic). As both concede, data for emerging local therapies very compelling, but possibly (possibly) a role for local + systemic.

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Great paper from Roger in Nature Medicine that supports this approach.”

sumanta k. pal

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Authors: Roger Li et al.

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Alexander R. A. Anderson Carlos M Moran Segura Colin P.N. Dinney Denise Dorman G. Daniel Grass Gustavo Borjas James J. Mulé James M. Burke Jasreman Dhillon Jingsong Zhang John J. Powers Jose R. Conejo-Garcia Joseph O. Johnson Julio M. Pow-Sang Logan Zemp Michael A. Poch Michiel van der Heijden Nancy Y. Villa Natasha Francis Paulo C. Rodriguez Philippe E. Spiess Roger Li Rohit K. Jain Scott M. Gilbert Tingyi Li Wade J. Sexton Xiaoqing Yu Xuefeng Wang Youngchul Kim
Special Coverage
Blog
Mar 10, 2025, 09:36
Sakditad Saowapa: Great catch and inspiring discussions at JSMO25
Insight
Mar 10, 2025, 09:32
Douglas Flora: Starting the Volume 2 of AI in Precision Oncology
Blog
Mar 10, 2025, 09:27
Roberto Iacovelli has received an Impact Award from European Urology Journal for the Tide-A Phase 2 study
Science
Mar 10, 2025, 09:12
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski
Blog
Mar 10, 2025, 08:54
Martin Kaiser: Co-occurrence of more than 2 HRCAs is associated with highest unmet need in NDMM and RRMM
Blog
Mar 10, 2025, 08:53
Nina Niu Sanford: 73 Questions with Dr. Bob Timmerman
Blog
Mar 10, 2025, 08:40
The Cancer Survivorship Group of Danish Cancer Institute
Blog
Mar 10, 2025, 08:34
The countdown is on for Women Leaders in Oncology 2025 - Vaniam Group
Blog
Mar 10, 2025, 08:32
Bishal Gyawali: Surrogate endpoints in cancer drug trials
Blog
Mar 10, 2025, 08:25
Prerna Mewawalla: Real-world outcomes of sequential BCMA-directed therapy in Multiple Myeloma
Science
Mar 10, 2025, 08:17
Does minimally invasive pancreatoduodenectomy offer real advantages? - SSO
Blog
Mar 10, 2025, 08:14
Peter Pisters: An inspiring evening at 'A Conversation With a Living Legend' event